Natalizumab Market Gains Momentum as Demand for Advanced Multiple Sclerosis Therapies Continues to Rise
https://growthmarketreports.co....m/report/natalizumab
The global natalizumab market reached USD 2.19 billion in 2025, driven by rising autoimmune disease prevalence and biologic therapy advances.
Gefällt mir
Kommentar
Teilen
